NEUROTROPHIC KERATITIS
Clinical trials for NEUROTROPHIC KERATITIS explained in plain language.
Never miss a new study
Get alerted when new NEUROTROPHIC KERATITIS trials appear
Sign up with your email to follow new studies for NEUROTROPHIC KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy eyedrop offers hope for rare corneal blindness
Disease control Recruiting nowThis study tests a new gene therapy called KB801 for people with stage 2 or 3 neurotrophic keratitis, a rare eye disease where the cornea loses feeling and can develop sores that won't heal. The treatment is an eyedrop that delivers a protein to help the cornea repair itself. Abo…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE1, PHASE2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated May 17, 2026 07:35 UTC
-
New eye drop could heal corneas in rare nerve damage disease
Disease control Recruiting nowThis study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a condition where the cornea loses feeling and can develop sores or ulcers. About 48 adults with moderate to severe disease will receive either the drug or a placebo for 8 weeks. Th…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE2 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New eye drops aim to restore feeling and healing to damaged corneas
Symptom relief Recruiting nowThis study tests an eye drop called Lacripep in 54 adults with neurotrophic keratitis, a condition where the cornea loses feeling and doesn't heal well. The goal is to see if the drops are safe and can improve the eye surface, vision, and comfort over 8 weeks. Participants will b…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE2 • Sponsor: TearSolutions, Inc. • Aim: Symptom relief
Last updated May 17, 2026 07:50 UTC